Literature DB >> 12213661

Regulation of viral transcription elongation and termination during vaccinia virus infection.

Richard C Condit1, Edward G Niles.   

Abstract

Vaccinia virus provides a useful genetic and biochemical tool for studies of the basic mechanisms of eukaryotic transcription. Vaccinia genes are transcribed in three successive gene classes during infection, early, intermediate, and late. Vaccinia transcription is regulated primarily by virus gene products not only during initiation, but also during elongation and termination. The factors and mechanisms regulating early elongation and termination differ from those regulating intermediate and late gene expression. Control of transcription elongation and termination in vaccinia virus bears some similarity to the same process in other prokaryotic and eukaryotic systems, yet features some novel mechanisms as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213661     DOI: 10.1016/s0167-4781(02)00461-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.

Authors:  Kristen L Willis; Jeffrey O Langland; Joanna L Shisler
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

2.  Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

Authors:  Ramtin Rahbar; Thomas T Murooka; Anna A Hinek; Carole L Galligan; Antonella Sassano; Celeste Yu; Kishore Srivastava; Leonidas C Platanias; Eleanor N Fish
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

4.  Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis.

Authors:  Susan M D'Costa; Travis W Bainbridge; Sayuri E Kato; Cindy Prins; Karen Kelley; Richard C Condit
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

5.  Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology.

Authors:  Patrícia N G Silva; Jamária A P Soares; Bruno S A F Brasil; Sarah V Nogueira; Anderson A Andrade; José C de Magalhães; Marisa B Bonjardim; Paulo C P Ferreira; Erna G Kroon; Oscar Bruna-Romero; Cláudio A Bonjardim
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

6.  Vaccinia reporter viruses for quantifying viral function at all stages of gene expression.

Authors:  Daniel K Rozelle; Claire Marie Filone; Ken Dower; John H Connor
Journal:  J Vis Exp       Date:  2014-05-15       Impact factor: 1.355

7.  Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes.

Authors:  Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

9.  Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.

Authors:  Shannon McNulty; William Bornmann; Jill Schriewer; Chas Werner; Scott K Smith; Victoria A Olson; Inger K Damon; R Mark Buller; John Heuser; Daniel Kalman
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

10.  Biochemical and biophysical properties of a putative hub protein expressed by vaccinia virus.

Authors:  Nicole E Kay; Travis W Bainbridge; Richard C Condit; Michael R Bubb; Reuben E Judd; Balasubramanian Venkatakrishnan; Robert McKenna; Susan M D'Costa
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.